Vanda Pharmaceuticals
VNDA
#7594
Rank
ยฃ0.29 B
Marketcap
ยฃ4.93
Share price
-2.22%
Change (1 day)
34.73%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -ยฃ91.26 Million

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.21 Billion. In 2024 the company made an earning of -ยฃ30.37 Million a decrease over its 2023 earnings that were of -ยฃ10.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ91.26 Million200.57%
2024 -ยฃ30.37 Million191.43%
2023 -ยฃ10.42 Million-320.45%
2022 ยฃ4.72 M-84.99%
2021 ยฃ31.48 M54.8%
2020 ยฃ20.33 M19.42%
2019 ยฃ17.03 M4.93%
2018 ยฃ16.23 M-228.6%
2017 -ยฃ12.63 Million-8.98%
2016 -ยฃ13.87 Million-53.79%
2015 -ยฃ30.01 Million-30.18%
2014 -ยฃ42.98 Million173.08%
2013 -ยฃ15.74 Million-25.33%
2012 -ยฃ21.08 Million163.61%
2011 -ยฃ8 Million-221.15%
2010 ยฃ6.59 M-124.53%
2009 -ยฃ26.91 Million-29.44%
2008 -ยฃ38.14 Million-36.2%
2007 -ยฃ59.77 Million21.81%
2006 -ยฃ49.07 Million170.55%
2005 -ยฃ18.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
ยฃ12.26 B-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
ยฃ16.80 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.19 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ5.99 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.85 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-ยฃ2.1 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ17.24 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA